Caspofungin Acetate molecular structure

Caspofungin Acetate

Also known as: Cancidas, Caspofungin Acetate for Injection, Caspomax, Caspogen

CAS Number: 179463-17-3

Echinocandin antifungal — systemic, parenteral

Pharmacopeia Standards

USPEP

Mechanism of Action

Caspofungin non-competitively inhibits beta-(1,3)-D-glucan synthase, the enzyme complex that polymerises the principal structural glucan of the fungal cell wall. Loss of beta-(1,3)-D-glucan leaves the wall osmotically unstable, producing fungicidal lysis of Candida species and growth arrest at the hyphal tips of Aspergillus. Because mammalian cells have no cell wall and no homologous enzyme, the class has a wide therapeutic margin and few off-target effects.

Technical Specifications

Generic / INN NameCaspofungin Acetate
CAS Registry Number179463-17-3
Molecular FormulaC52H88N10O15·2C2H4O2
Molecular Weight1213.42 g/mol
Typical Purity95.0–102.0% (on anhydrous, acetate-free basis)
Storage ConditionsStore at −20°C or 2–8°C as per specification, in tightly closed, light-resistant containers under nitrogen; protect from light and moisture
Shelf Life24 months from date of manufacture when stored as specified
CategoryEchinocandins

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Candidaemia and invasive candidiasis, oesophageal candidiasis, salvage therapy of invasive aspergillosis, empirical antifungal therapy in persistent febrile neutropenia

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.